메뉴 건너뛰기




Volumn 84, Issue 4, 2009, Pages 231-233

Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATININE; HYDROXYUREA; LEUKOTRIENE E4; MONTELUKAST; ACETIC ACID DERIVATIVE; ANTIASTHMATIC AGENT; BIOLOGICAL MARKER; HEMOGLOBIN F; LEUKOTRIENE RECEPTOR BLOCKING AGENT; QUINOLINE DERIVATIVE;

EID: 64549155231     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21370     Document Type: Article
Times cited : (24)

References (16)
  • 1
    • 0025770390 scopus 로고
    • Pain in sickle cell disease. Rates and risk factors
    • Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-16.
    • (1991) N Engl J Med , vol.325 , pp. 11-16
    • Platt, O.S.1    Thorington, B.D.2    Brambilla, D.J.3
  • 4
    • 0028000652 scopus 로고
    • Cysteinyl leukotrienes in the urine of patients with liver diseases
    • Baltimore, MD
    • Uemura M, Buchholz U, Kojima H, et al. Cysteinyl leukotrienes in the urine of patients with liver diseases. Hepatology (Baltimore, MD) 1994;20:804-812.
    • (1994) Hepatology , vol.20 , pp. 804-812
    • Uemura, M.1    Buchholz, U.2    Kojima, H.3
  • 5
    • 0024605525 scopus 로고
    • Analysis of cysteinyl leukotrienes in human urine: Enhanced excretion in patients with liver cirrhosis and hepatorenal syndrome
    • Huber M, Kastner S, Scholmerich J, et al. Analysis of cysteinyl leukotrienes in human urine: Enhanced excretion in patients with liver cirrhosis and hepatorenal syndrome. Eur J Clin Invest 1989;19:53-60.
    • (1989) Eur J Clin Invest , vol.19 , pp. 53-60
    • Huber, M.1    Kastner, S.2    Scholmerich, J.3
  • 7
    • 0027340363 scopus 로고
    • Leukotriene E4 and granulocytic infiltration into asthmatic airways
    • Laitinen LA, Laitinen A, Haahtela T, et al. Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 1993;341:989-990.
    • (1993) Lancet , vol.341 , pp. 989-990
    • Laitinen, L.A.1    Laitinen, A.2    Haahtela, T.3
  • 8
    • 0028845948 scopus 로고
    • Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells
    • Datta YH, Romano M, Jacobson BC, et al. Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells. Circulation 1995;92:3304-3311.
    • (1995) Circulation , vol.92 , pp. 3304-3311
    • Datta, Y.H.1    Romano, M.2    Jacobson, B.C.3
  • 9
    • 0000951027 scopus 로고
    • Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro
    • Drazen JM, Austen KF, Lewis RA, et al. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci USA 1980;77:4354-4358.
    • (1980) Proc Natl Acad Sci USA , vol.77 , pp. 4354-4358
    • Drazen, J.M.1    Austen, K.F.2    Lewis, R.A.3
  • 10
    • 0023117443 scopus 로고
    • The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction
    • Joris I, Majno G, Corey EJ, Lewis RA. The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction. Am J Pathol 1987;126:19-24.
    • (1987) Am J Pathol , vol.126 , pp. 19-24
    • Joris, I.1    Majno, G.2    Corey, E.J.3    Lewis, R.A.4
  • 12
    • 65949112678 scopus 로고    scopus 로고
    • The Leukotriene Pathway in Sickle Cell Disease: A potential target for directed therapy
    • Knight-Perry JE, DeBaun MR, Strunk RC, Field JJ. The Leukotriene Pathway in Sickle Cell Disease: A potential target for directed therapy. Expert Rev Hematol 2009;2:57-68.
    • (2009) Expert Rev Hematol , vol.2 , pp. 57-68
    • Knight-Perry, J.E.1    DeBaun, M.R.2    Strunk, R.C.3    Field, J.J.4
  • 13
    • 49149105638 scopus 로고    scopus 로고
    • Elevated urinary leukotriene E(4) levels are associated with hospitalization for pain in children with sickle cell disease
    • Jennings JE, Ramkumar T, Mao J, et al. Elevated urinary leukotriene E(4) levels are associated with hospitalization for pain in children with sickle cell disease. Am J Hematol 2008;83:640-643.
    • (2008) Am J Hematol , vol.83 , pp. 640-643
    • Jennings, J.E.1    Ramkumar, T.2    Mao, J.3
  • 14
    • 62949207155 scopus 로고    scopus 로고
    • Urinary cysteinyl leukotriene E4 is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease
    • in press
    • Field JJ KJ, White NL, Yan Y, et al. Urinary cysteinyl leukotriene E4 is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease. Am J of Hematol 2009, in press.
    • (2009) Am J of Hematol
    • Field, J.J.K.J.1    White, N.L.2    Yan, Y.3
  • 15
    • 31844443695 scopus 로고
    • The environment and disease: Association or causation?
    • Hill A. The environment and disease: Association or causation? Proc R Soc Med 1965;58:293-300.
    • (1965) Proc R Soc Med , vol.58 , pp. 293-300
    • Hill, A.1
  • 16
    • 55549139821 scopus 로고    scopus 로고
    • Sibling history of asthma is a risk factor for pain in children with sickle cell anemia
    • Field JJ, Yan Y, Strunk RC, DeBaun MR. Sibling history of asthma is a risk factor for pain in children with sickle cell anemia. Am J Hematol 2008;83:855-857.
    • (2008) Am J Hematol , vol.83 , pp. 855-857
    • Field, J.J.1    Yan, Y.2    Strunk, R.C.3    DeBaun, M.R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.